Developer docs
API playgroundTry for free, no card

Search company profiles

contextflow

Full company profile

uuid0002dym

Namestring
contextflow
Legal namestring
contextflow GmbH
Websiteurl
contextflow.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

contextflow GmbH is a Vienna-based medical AI company, spun out in July 2016 from the Medical University of Vienna, TU Wien, and the European KHRESMOI research project, that builds deep-learning software for chest CT analysis used by radiologists in hospitals and imaging centers. Its AI Solution Suite is anchored by ADVANCE Chest CT (CE Marked, UKCA marked), which performs nodule detection and quantification, longitudinal tracking, quantitative lung tissue analysis, and qualitative recognition of 19 image patterns, supplemented by a 3D image-based similarity search engine (SEARCH), an automated triage module (TRIAGE), and bundled CE-marked modules for malignancy scoring (RevealAI-Lung from RevealDx) and incidental pulmonary embolism detection (CINA-iPE from Avicenna). The technology is trained on a curated knowledge base of 8,000+ clinical lung CT scans and operates natively inside hospital PACS environments including Sectra, Neologica LogiPACS, and the Blackford AI platform.

The company sells primarily via annual subscription or on-premise software licenses priced per installation location, with quote-based enterprise pricing reflecting institution size, deployment type (cloud vs on-premise), and feature modules selected. Its go-to-market combines direct enterprise field sales to radiology departments, channel partnerships (Blackford/Bayer, Neologica, Curagita, Mint Medical, Collective Minds Radiology), and event-driven demand generation via major radiology conferences and webinar series. End customers include academic medical centers (Erasmus MC, University Medical Center Freiburg, Medical University of Innsbruck, Leiden UMC, Vienna General Hospital), large hospital networks (Imapôle Lyon-Villeurbanne processing 170,000 chest CTs per year, NHS SW London Imaging Network, Providence Little Company of Mary Medical Centers), and pharmaceutical companies using quantitative imaging for clinical trials. The company holds ISO 13485:2016, EU MDR CE Marking, and UKCA, with FDA 510(k) pursued via the announced June 2026 acquisition by Australia's 4DMedical, under which contextflow CEO Markus Holzer will lead the combined entity's European operations as General Manager.

Short descriptiontext

contextflow is a Vienna-based medical AI company that develops CE-marked deep-learning software for chest CT analysis, helping radiologists detect, quantify, and manage lung cancer, lung diseases, and incidental pulmonary embolism directly within their PACS workflow.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVienna, Austria
HQ citystring
Vienna
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiology AI software, medical image analysis, chest CT detection, computer-aided detection, lung disease AI
Industry4 codes
PRIMARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACABAI
Clinical Document & Data Exchange (C-CDA, CCD, Direct Messaging)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Radiology AI Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Software License and Subscription
TypeSubscription Recurring
Description

Non-exclusive, non-transferable software licenses delivered as SaaS or on-premise deployments. Licensed per installation location with pricing based on usage scope and institutional size.

contextflow.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others
Pricing details1 tier
1Enterprise hospital deployment
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing tailored to institution size, deployment type (cloud vs on-premise), and feature modules selected. Pricing is per installation location with multi-year contract options.

contextflow.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

contextflow develops and sells an AI Solution Suite for chest CT analysis used by radiologists to detect, quantify, and manage lung cancer, interstitial lung disease, COPD, and incidental pulmonary embolism. The suite is anchored by the CE-marked ADVANCE Chest CT product, which adds RevealAI-Lung malignancy scoring (from RevealDx) and CINA-iPE (from Avicenna) as integrated modules, and is delivered as SaaS or on-premise software licensed to hospitals, PACS vendors, and pharmaceutical companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Average report reading time reduced 31% in clinical study with Medical University of Vienna
+1 more record
Product overview1 text field

contextflow offers an AI Solution Suite for chest CT analysis consisting of well-integrated tools to help radiologists detect, quantify, and manage lung cancer, lung diseases, and incidental pulmonary embolism. The core product is ADVANCE Chest CT (CE Marked), which provides comprehensive computer-aided detection support including nodule detection, lung tissue analysis, and 19 disease pattern recognition. This core platform integrates with RevealAI-Lung (from RevealDx) for malignancy scoring and CINA-iPE (from Avicenna) for incidental pulmonary embolism detection, all CE Marked. The suite is available directly to radiologists and through enterprise AI platform partners like Blackford, and integrates natively into PACS systems including Sectra, Neologica LogiPACS, and others. contextflow also collaborates with Mint Medical on Germany's upcoming lung cancer screening program.

Product and service3 records
1ADVANCE Chest CT
CategoryRadiology AI Software
Description

Comprehensive computer-aided detection support for suspected lung cancer, ILD, and COPD on chest CT. Features nodule detection and quantification, nodule tracking over time, quantitative lung tissue analysis, and qualitative analysis of 19 image patterns plus reference cases and differential diagnosis information. CE Marked and available for clinical use in Europe under EU MDR 2017/745. Sold to radiologists, hospitals, PACS vendors, and pharmaceutical companies.

2RevealAI-Lung
CategoryRadiology AI Software
Description

Malignancy scoring solution from RevealDx distributed as part of contextflow's AI Solution Suite, producing a Malignancy Similarity Index to assist radiologists in making follow-up recommendations for lung cancer diagnosis. Aims to reduce unnecessary procedures and detect lung cancer up to one year sooner. CE Marked.

3CINA-iPE
CategoryRadiology AI Software
Description

Incidental pulmonary embolism detection tool from Avicenna, distributed as part of contextflow's AI Solution Suite to ensure radiologists do not miss pulmonary embolism findings on chest CT. CE Marked.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-10
Description

4DMedical announced acquisition of contextflow to expand AI-driven lung imaging capabilities in Europe. The all-share transaction combines cash, shares, and performance-based options, providing 4DMedical with CE-marked products, established customer relationships, European reimbursement pathways, and access to the European respiratory and thoracic imaging market. contextflow CEO Markus Holzer will serve as General Manager of Europe post-acquisition. The combined entity plans to expand beyond functional lung imaging into AI-assisted lung cancer screening.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-04-17
Description

Collaboration on lung cancer screening webinar series in Germany. Contextflow and Mint Medical developed a solution to ensure efficient and consistent reporting within lung cancer screening guidelines as Germany's nationwide LCS program launches.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-28
Description

Partnership with Korean imaging AI firm VUNO to advance cardiac arrest prediction solution (VUNO Med-DeepCARS) in Europe. contextflow contributes its experience with European reimbursement listing for imaging AI technologies. The three-party MOU with Mesalvo enables system integration, clinical validation, and reimbursement pathways to help DeepCARS adoption in European hospitals.

4Mesalvo
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-28
Description

German HIS provider supplying hospital information systems across Germany and other European countries. Plans to integrate DeepCARS with electronic medical record and data platforms. Partnership enables access to over 900 hospitals for VUNO's DeepCARS solution.

contextflow.com
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-05-30
Description

Partnership to improve lung cancer and lung disease diagnostics in Germany through collaboration on chest imaging analysis solutions.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-05-30
Description

Pilot collaboration with University Hospitals Leuven to advance chest imaging analysis, leveraging academic medical center expertise in radiology workflows.

7Neologica
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-06-05
Description

Commercial partnership to integrate contextflow ADVANCE Chest CT into Neologica's LogiPACS, bringing comprehensive chest CT support to Neologica's radiology customer base. Founded in 2002, Neologica develops advanced medical imaging software solutions.

contextflow.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-11-16
Description

Commercial partnership to bring contextflow's ADVANCE Chest CT solution to healthcare providers through Blackford's strategic AI platform. Integration with Blackford's enterprise AI platform provides access to extensive portfolio of medical AI solutions designed to drive clinical efficiency and improve patient outcomes. Blackford was subsequently acquired by Bayer.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-07-24
Description

Partnership to indicate treatment effectiveness and predict disease progression in non-small cell lung cancer (NSCLC) using quantitative imaging analysis.

10Medical University of Vienna
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Core academic founding partner and spin-off origin. Provides clinical data, research collaboration, and scientific validation for AI development. Home to Computational Image Analysis and Radiology Lab (CIR) led by Georg Langs.

contextflow.com
11Technical University of Vienna (TU Wien)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic founding partner providing technical expertise in computer vision, machine learning, and data intelligence research.

contextflow.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research partnership with prestigious international academic institution for advanced AI research in medical imaging.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Swiss representative office at Bahnhofplatz, CH-6300 Zug for regulatory and market access support in Switzerland.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI company providing chest X-ray and CT interpretation algorithms including lung nodule and lung disease detection. Targets the same radiology customer base globally with FDA-cleared and CE-marked products.

TypeDirect peer
Description

Comprehensive radiology AI platform covering chest CT findings among other modalities. Comparable as a deep learning radiology decision-support vendor with broad pattern recognition capabilities targeting enterprise radiology customers.

TypeDirect peer
Description

Israel-based AI radiology platform offering triage and detection algorithms across multiple modalities including chest CT. Directly comparable as a vendor selling AI-powered imaging analysis tools to hospital radiology departments with similar enterprise field sales motion.

4Avicenna AI
TypeDirect peer
Description

French medical imaging AI company whose CINA-iPE product is integrated and distributed by contextflow. Direct peer in the AI-powered incidental pulmonary embolism detection space with similar regulatory and commercial profile.

TypeDirect peer
Description

Cloud-native radiology AI platform with FDA-cleared chest CT cardiac and lung analysis tools. Comparable as a venture-backed radiology AI vendor targeting enterprise imaging customers with PACS-integrated workflow solutions.

TypeDirect peer
Description

Enterprise AI imaging platform focused on time-sensitive findings (initially stroke, expanding into other conditions). Comparable as a venture-backed radiology AI company selling workflow-integrated detection tools to hospital systems.

TypeBroad incumbent
Description

Global medical imaging vendor with AI-Rad Companion and other AI imaging offerings natively integrated with their PACS and imaging hardware. Represents the incumbent competitive threat with installed base leverage.

TypeDirect peer
Description

Specializes in chest imaging AI including ClearRead CT for nodule detection, directly overlapping with contextflow's lung nodule detection and lung disease analysis capabilities. Targets the same radiologist customer base with PACS-integrated solutions.

TypeDirect peer
Description

Lung cancer malignancy scoring AI whose RevealAI-Lung product is integrated with contextflow's ADVANCE Chest CT. Direct peer in lung nodule risk assessment with overlapping customer base and regulatory pathway.

TypeBroad incumbent
Description

Enterprise AI platform for radiology that distributes contextflow's ADVANCE Chest CT alongside a broader portfolio of medical imaging AI solutions. Acquired by Bayer, providing a broader distribution umbrella for AI imaging applications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

contextflow

Radiology AI Softwarecontextflow.com

contextflow is a Vienna-based medical AI company that develops CE-marked deep-learning software for chest CT analysis, helping radiologists detect, quantify, and manage lung cancer, lung diseases, and incidental pulmonary embolism directly within their PACS workflow.

What contextflow does

contextflow GmbH is a Vienna-based medical AI company, spun out in July 2016 from the Medical University of Vienna, TU Wien, and the European KHRESMOI research project, that builds deep-learning software for chest CT analysis used by radiologists in hospitals and imaging centers. Its AI Solution Suite is anchored by ADVANCE Chest CT (CE Marked, UKCA marked), which performs nodule detection and quantification, longitudinal tracking, quantitative lung tissue analysis, and qualitative recognition of 19 image patterns, supplemented by a 3D image-based similarity search engine (SEARCH), an automated triage module (TRIAGE), and bundled CE-marked modules for malignancy scoring (RevealAI-Lung from RevealDx) and incidental pulmonary embolism detection (CINA-iPE from Avicenna). The technology is trained on a curated knowledge base of 8,000+ clinical lung CT scans and operates natively inside hospital PACS environments including Sectra, Neologica LogiPACS, and the Blackford AI platform.

The company sells primarily via annual subscription or on-premise software licenses priced per installation location, with quote-based enterprise pricing reflecting institution size, deployment type (cloud vs on-premise), and feature modules selected. Its go-to-market combines direct enterprise field sales to radiology departments, channel partnerships (Blackford/Bayer, Neologica, Curagita, Mint Medical, Collective Minds Radiology), and event-driven demand generation via major radiology conferences and webinar series. End customers include academic medical centers (Erasmus MC, University Medical Center Freiburg, Medical University of Innsbruck, Leiden UMC, Vienna General Hospital), large hospital networks (Imapôle Lyon-Villeurbanne processing 170,000 chest CTs per year, NHS SW London Imaging Network, Providence Little Company of Mary Medical Centers), and pharmaceutical companies using quantitative imaging for clinical trials. The company holds ISO 13485:2016, EU MDR CE Marking, and UKCA, with FDA 510(k) pursued via the announced June 2026 acquisition by Australia's 4DMedical, under which contextflow CEO Markus Holzer will lead the combined entity's European operations as General Manager.

contextflow firmographics

Firmographics
Name
contextflow
Legal name
contextflow GmbH
Website
https://contextflow.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
contextflow is a Vienna-based medical AI company that develops CE-marked deep-learning software for chest CT analysis, helping radiologists detect, quantify, and manage lung cancer, lung diseases, and incidental pulmonary embolism directly within their PACS workflow.
Ownership category
akta.pro rank

contextflow industry classification

Industry
Product category
Radiology AI Software
NAICS
Medical Equipment and Supplies Manufacturing (3391)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACABAI
Clinical Document & Data Exchange (C-CDA, CCD, Direct Messaging)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability

Keywords

  • Radiology AI software
  • Medical image analysis
  • Chest CT detection
  • Computer-aided detection
  • Lung disease AI

Where contextflow is headquartered

Location

Headquarters

HQ city
Vienna
HQ country
Austria
HQ region
Europe

Offices2 records

Markets served

contextflow business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Software License and Subscription: Non-exclusive, non-transferable software licenses delivered as SaaS or on-premise deployments. Licensed per installation location with pricing based on usage scope and institutional size.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise hospital deployment

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

contextflow product offering

Product offering

Core offering

contextflow develops and sells an AI Solution Suite for chest CT analysis used by radiologists to detect, quantify, and manage lung cancer, interstitial lung disease, COPD, and incidental pulmonary embolism. The suite is anchored by the CE-marked ADVANCE Chest CT product, which adds RevealAI-Lung malignancy scoring (from RevealDx) and CINA-iPE (from Avicenna) as integrated modules, and is delivered as SaaS or on-premise software licensed to hospitals, PACS vendors, and pharmaceutical companies.

Product overview

contextflow offers an AI Solution Suite for chest CT analysis consisting of well-integrated tools to help radiologists detect, quantify, and manage lung cancer, lung diseases, and incidental pulmonary embolism. The core product is ADVANCE Chest CT (CE Marked), which provides comprehensive computer-aided detection support including nodule detection, lung tissue analysis, and 19 disease pattern recognition. This core platform integrates with RevealAI-Lung (from RevealDx) for malignancy scoring and CINA-iPE (from Avicenna) for incidental pulmonary embolism detection, all CE Marked. The suite is available directly to radiologists and through enterprise AI platform partners like Blackford, and integrates natively into PACS systems including Sectra, Neologica LogiPACS, and others. contextflow also collaborates with Mint Medical on Germany's upcoming lung cancer screening program.

Differentiator

Problem solved

Functional benefit

Products and services

  • ADVANCE Chest CT Comprehensive computer-aided detection support for suspected lung cancer, ILD, and COPD on chest CT. Features nodule detection and quantification, nodule tracking over time, quantitative lung tissue analysis, and qualitative analysis of 19 image patterns plus reference cases and differential diagnosis information. CE Marked and available for clinical use in Europe under EU MDR 2017/745. Sold to radiologists, hospitals, PACS vendors, and pharmaceutical companies.
  • RevealAI-Lung Malignancy scoring solution from RevealDx distributed as part of contextflow's AI Solution Suite, producing a Malignancy Similarity Index to assist radiologists in making follow-up recommendations for lung cancer diagnosis. Aims to reduce unnecessary procedures and detect lung cancer up to one year sooner. CE Marked.
  • CINA-iPE Incidental pulmonary embolism detection tool from Avicenna, distributed as part of contextflow's AI Solution Suite to ensure radiologists do not miss pulmonary embolism findings on chest CT. CE Marked.

Quantifiable outcome

  • Average report reading time reduced 31% in clinical study with Medical University of Vienna
  • +1 more outcomes

Companies that use contextflow

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles3 records

contextflow technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability7 records

Feature6 records

contextflow partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core, major and minor.

  • 4DMedicalcoreStrategic or Co-development Partner · 10 June 20264DMedical announced acquisition of contextflow to expand AI-driven lung imaging capabilities in Europe. The all-share transaction combines cash, shares, and performance-based options, providing 4DMedical with CE-marked products, established customer relationships, European reimbursement pathways, and access to the European respiratory and thoracic imaging market. contextflow CEO Markus Holzer will serve as General Manager of Europe post-acquisition. The combined entity plans to expand beyond functional lung imaging into AI-assisted lung cancer screening.
  • Mint MedicalmajorStrategic or Co-development Partner · 17 April 2026Collaboration on lung cancer screening webinar series in Germany. Contextflow and Mint Medical developed a solution to ensure efficient and consistent reporting within lung cancer screening guidelines as Germany's nationwide LCS program launches.
  • VUNOcoreStrategic or Co-development Partner · 28 October 2025Partnership with Korean imaging AI firm VUNO to advance cardiac arrest prediction solution (VUNO Med-DeepCARS) in Europe. contextflow contributes its experience with European reimbursement listing for imaging AI technologies. The three-party MOU with Mesalvo enables system integration, clinical validation, and reimbursement pathways to help DeepCARS adoption in European hospitals.
  • MesalvocoreTechnology or Integration · 28 October 2025German HIS provider supplying hospital information systems across Germany and other European countries. Plans to integrate DeepCARS with electronic medical record and data platforms. Partnership enables access to over 900 hospitals for VUNO's DeepCARS solution.
  • CuragitamajorChannel Partner/ Reseller/ Distributor · 30 May 2025Partnership to improve lung cancer and lung disease diagnostics in Germany through collaboration on chest imaging analysis solutions.
  • UZ LeuvenmajorStrategic or Co-development Partner · 30 May 2025Pilot collaboration with University Hospitals Leuven to advance chest imaging analysis, leveraging academic medical center expertise in radiology workflows.
  • NeologicamajorChannel Partner/ Reseller/ Distributor · 5 June 2024Commercial partnership to integrate contextflow ADVANCE Chest CT into Neologica's LogiPACS, bringing comprehensive chest CT support to Neologica's radiology customer base. Founded in 2002, Neologica develops advanced medical imaging software solutions.
  • BlackfordcoreChannel Partner/ Reseller/ Distributor · 16 November 2023Commercial partnership to bring contextflow's ADVANCE Chest CT solution to healthcare providers through Blackford's strategic AI platform. Integration with Blackford's enterprise AI platform provides access to extensive portfolio of medical AI solutions designed to drive clinical efficiency and improve patient outcomes. Blackford was subsequently acquired by Bayer.
  • MedexprimminorStrategic or Co-development Partner · 24 July 2023Partnership to indicate treatment effectiveness and predict disease progression in non-small cell lung cancer (NSCLC) using quantitative imaging analysis.
  • Medical University of ViennacoreStrategic or Co-development PartnerCore academic founding partner and spin-off origin. Provides clinical data, research collaboration, and scientific validation for AI development. Home to Computational Image Analysis and Radiology Lab (CIR) led by Georg Langs.
  • Technical University of Vienna (TU Wien)coreStrategic or Co-development PartnerAcademic founding partner providing technical expertise in computer vision, machine learning, and data intelligence research.
  • University of CambridgemajorStrategic or Co-development PartnerResearch partnership with prestigious international academic institution for advanced AI research in medical imaging.
  • Freyr Life SciencesminorChannel Partner/ Reseller/ DistributorSwiss representative office at Bahnhofplatz, CH-6300 Zug for regulatory and market access support in Switzerland.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

contextflow competitors and assessment

Company assessment

Direct peers

  • Qure.ai: AI company providing chest X-ray and CT interpretation algorithms including lung nodule and lung disease detection. Targets the same radiology customer base globally with FDA-cleared and CE-marked products.
  • Annalise.ai: Comprehensive radiology AI platform covering chest CT findings among other modalities. Comparable as a deep learning radiology decision-support vendor with broad pattern recognition capabilities targeting enterprise radiology customers.
  • Aidoc: Israel-based AI radiology platform offering triage and detection algorithms across multiple modalities including chest CT. Directly comparable as a vendor selling AI-powered imaging analysis tools to hospital radiology departments with similar enterprise field sales motion.
  • Avicenna AI: French medical imaging AI company whose CINA-iPE product is integrated and distributed by contextflow. Direct peer in the AI-powered incidental pulmonary embolism detection space with similar regulatory and commercial profile.
  • Arterys (Tempus): Cloud-native radiology AI platform with FDA-cleared chest CT cardiac and lung analysis tools. Comparable as a venture-backed radiology AI vendor targeting enterprise imaging customers with PACS-integrated workflow solutions.
  • Viz.ai: Enterprise AI imaging platform focused on time-sensitive findings (initially stroke, expanding into other conditions). Comparable as a venture-backed radiology AI company selling workflow-integrated detection tools to hospital systems.
  • Riverain Technologies: Specializes in chest imaging AI including ClearRead CT for nodule detection, directly overlapping with contextflow's lung nodule detection and lung disease analysis capabilities. Targets the same radiologist customer base with PACS-integrated solutions.
  • RevealDx: Lung cancer malignancy scoring AI whose RevealAI-Lung product is integrated with contextflow's ADVANCE Chest CT. Direct peer in lung nodule risk assessment with overlapping customer base and regulatory pathway.

Broad incumbents

  • Siemens Healthineers: Global medical imaging vendor with AI-Rad Companion and other AI imaging offerings natively integrated with their PACS and imaging hardware. Represents the incumbent competitive threat with installed base leverage.
  • Blackford Analysis (Bayer): Enterprise AI platform for radiology that distributes contextflow's ADVANCE Chest CT alongside a broader portfolio of medical imaging AI solutions. Acquired by Bayer, providing a broader distribution umbrella for AI imaging applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

contextflow social profiles

Digital presence

contextflow compliance and trust

Trust signal

Compliance5 records

contextflow financial estimates

Financial estimate

Revenue estimate

Valuation estimate

contextflow leadership team

Management profile

Number of profiles

Profiles11 records

contextflow funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

contextflow M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about contextflow

What does contextflow do?

contextflow develops and sells an AI Solution Suite for chest CT analysis used by radiologists to detect, quantify, and manage lung cancer, interstitial lung disease, COPD, and incidental pulmonary embolism. The suite is anchored by the CE-marked ADVANCE Chest CT product, which adds RevealAI-Lung malignancy scoring (from RevealDx) and CINA-iPE (from Avicenna) as integrated modules, and is delivered as SaaS or on-premise software licensed to hospitals, PACS vendors, and pharmaceutical companies.

Is contextflow a public or private company?

contextflow is a private company. It is classified as venture growth investor backed and is currently operating.

When was contextflow founded?

contextflow was founded in 2016. It employs 11 to 50 people.

Where is contextflow based?

contextflow is headquartered in Vienna, Austria, in the Europe region.

How does contextflow make money?

One revenue line is on record: software License and Subscription.

Who are contextflow's main competitors?

Direct peers on record are Qure.ai, Annalise.ai, Aidoc, Avicenna AI, Arterys (Tempus), Viz.ai, Riverain Technologies and RevealDx. Broad incumbents are Siemens Healthineers and Blackford Analysis (Bayer).

Does contextflow have an API?

No public API is recorded for contextflow.

What industry is contextflow in?

contextflow's product category is Radiology AI Software. Its primary akta.pro industry code is HLACALAD, Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic), with a secondary code of HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation. Its NAICS code is 3391 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Med-Tech InsightsRevealDx announces distribution agreement and investment from 4DMedicalRevealDx announced a distribution agreement and $3.4 million investment from 4DMedical, expanding access to its RevealAI-Lung product. The software, validated on over 1,500 patients, has received MDR, TGA, and FDA clearance. 4DMedical's acquisition of contextflow integrates RevealAI-Lung into its platform.CeelegalmattersBrandl Talos Advises Shareholders of Contextflow on Sale to 4DMedicalBrandl Talos advised the shareholders of Contextflow on the sale of the company to 4DMedical, with Binder Groesswang working alongside Gadens to advise the buyer. Contextflow is a Vienna-based company specializing in AI-powered lung imaging and radiology workflow solutions, while 4DMedical is an Australian Securities Exchange-listed medical technology company. The transaction expands 4DMedical's capabilities in AI-driven medical imaging through the acquisition of Contextflow.Pulse 2.04DMedical: Acquisition Of Contextflow Expands European Lung Imaging Presence4DMedical announced an agreement to acquire Austrian lung imaging software company contextflow, establishing an immediate commercial and clinical platform in Europe. The all-share transaction combines cash, shares, and performance-based options, providing 4DMedical with CE-marked products, established customer relationships, European reimbursement pathways, and access to the continent's respiratory and thoracic imaging market without building operations organically. Following the acquisition, contextflow CEO Markus Holzer will serve as General Manager of Europe, while the combined entity will expand beyond functional lung imaging into AI-assisted lung cancer screening.4Dmedical4DMedical Expands into Europe with Agreement to Acquire Software Lung Imaging Leader contextflow4DMedical signed a binding agreement to acquire Vienna-based contextflow GmbH, a lung imaging software company. The deal adds CE-marked products and MDR-aligned regulatory capabilities, combining structural and functional lung imaging tools. It strengthens 4DMedical's global footprint across North America, Europe, and Australia.Trending Topicscontextflow: MedTech Giant 4DMedical Acquires Vienna Startup for More Than €11.4 MillionAustralian medtech company 4DMedical Limited has acquired Vienna-based AI lung diagnostics startup contextflow GmbH for approximately €11.4 million in cash plus shares and earnout components. The acquisition provides 4DMedical with immediate entry into the European market, including CE-certified products, an existing customer base, and approximately €19 million in tax loss carryforwards. The deal also combines contextflow's detection-focused AI capabilities with 4DMedical's functional imaging technology to create a more comprehensive clinical pathway from detection through diagnosis to monitoring.Signify ResearchMedical Imaging AI Market Update – May 2026The medical imaging AI market saw continued growth in May 2026, with new acquisitions, product launches, partnerships, and regulatory approvals. Significant activities included 4D Medical's acquisition of contextflow, Viz.ai's launch of the Viz Pulmonary Suite, and FDA clearances for AZmed and DeepHealth. The market focus shifted toward clinical integration, real-world adoption, and expanding AI's role in disease screening and management.The Manila TimesVUNO Partners with European Firms to Advance DeepCARS® Market Entry in EuropeVUNO signed a strategic MOU with Austrian imaging AI firm Contextflow and German HIS provider Mesalvo to advance its AI cardiac arrest prediction solution DeepCARS in Europe. The partnership aims to integrate DeepCARS into Mesalvo's EHR systems, potentially reaching over 900 hospitals. DeepCARS has been implemented across more than 50,000 hospital beds in South Korea as of September 2025.Contextflowcontextflow collaborates with VUNO and Mesalvo to advance cardiac arrest prediction solution – contextflowcontextflow has partnered with Korean AI firm VUNO and German hospital information systems provider Mesalvo to accelerate the launch of VUNO's cardiac arrest prediction solution, DeepCARS, in Europe. The collaboration involves system integration, clinical validation, and reimbursement strategies to facilitate adoption across over 900 European hospitals. This strategic alliance marks the beginning of DeepCARS' full-scale expansion into the European market.CB InsightsProducts, Competitors, Financials, Employees, Headquarters LocationsVUNO Inc. signed a strategic Memorandum of Understanding with Contextflow and Mesalvo to advance the market entry of its AI-based cardiac arrest prediction solution, DeepCARS®, in Europe. The partnership involves technical integration into Mesalvo's hospital information systems, leveraging Contextflow for regulatory and reimbursement support, potentially reaching over 900 hospitals across the region. This collaboration was announced during the ESICM LIVES 2025 congress in Munich.